Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Anti-Cancer Drug Shows Few Side-Effects in Mice

October 23, 2014 10:15 am | News | Comments

A new drug, known as OTS964, can eradicate aggressive human lung cancers transplanted into mice, according to a new report. Read more...                     

TOPICS:

New Study Finds Potential Targets for Personalized Cancer Vaccines

October 23, 2014 10:01 am | News | Comments

A team of University of Notre Dame scientists, in collaboration with researchers at the University of Connecticut, have announced the results of a new study on identifying potential targets for personalized cancer vaccines. Read more...    

TOPICS:

Eli Lilly Adds $375M to Zymeworks Partnership

October 23, 2014 9:52 am | News | Comments

Eli Lilly and Zymeworks said they are expanding a cancer drug development partnership. Read more...                                                   

TOPICS:
Advertisement

Microscopic “Walkers” Find Way Across Cell Surfaces

October 23, 2014 9:47 am | News | Comments

Technology could provide a way to deliver probes or drugs to cell structures without outside guidance. Read more...                                         

TOPICS:

Sutro BioPharma and Celgene Announce New Collaboration Plan

October 23, 2014 9:41 am | News | Comments

Sutro Biopharma announced it has entered into a strategic collaboration and option agreement with Celgene Corporation to discover and develop multispecific antibodies and antibody drug conjugates. Read more...                

TOPICS:

U.S. to Track Everyone Coming from Ebola Nations

October 23, 2014 9:26 am | by Mike Stobbe - AP Medical Writer | News | Comments

All travelers who come into the U.S. from three Ebola-stricken West African nations will now be monitored for three weeks. Read more...                     

TOPICS:

NIH Begins Early Human Clinical Trial of New Ebola Vaccine

October 22, 2014 2:00 pm | News | Comments

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. Read more...                

TOPICS:

UNC Researchers Found New Characters In Cancer Cells

October 22, 2014 1:47 pm | News | Comments

UNC School of Medicine researchers have pinpointed a set of intriguing characteristics in a previously unknown subpopulation of melanoma cancer cells in blood vessels of tumors. Read more...            

TOPICS:
Advertisement

PhosImmune, PureMHC Working Together on Cancer Immunotherapies

October 22, 2014 1:28 pm | News | Comments

PhosImmune Inc. and PureMHC LLC announced they have entered into a license and collaboration agreement to develop novel antibody-based immunotherapies designed to target cancers. Read more...

TOPICS:

Biogen Slides as MS Drug Linked to Inflammation

October 22, 2014 1:20 pm | News | Comments

Shares of Biogen Idec slumped 8% after the pharmaceutical said a patient who took its newest multiple sclerosis drug suffered a brain inflammation and later died. Read more...                            

TOPICS:

Taiho Receives FDA Fast Track for Cancer Treatment

October 22, 2014 1:14 pm | News | Comments

Taiho Oncology Inc. announced that the FDA granted Fast Track designation for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer (mCRC). Read more...

TOPICS:

Third Point Urges Amgen to Consider Breakup

October 22, 2014 12:49 pm | News | Comments

A hedge fund run by a famed investor said it has taken a large stake in Amgen and now wants the biotech drugmaker to consider splitting up into two. Read more....               

TOPICS:

Study Finds Drugs Still in Recalled Supplements

October 22, 2014 11:48 am | by Lindsey Tanner, AP Medical Writer | News | Comments

Dietary supplements containing potentially dangerous prescription drug ingredients may still be for sale even years after safety recalls, a study found. Read more...                              

TOPICS:

Actavis Signs Option to Acquire Rhythm Subsidiary

October 22, 2014 10:24 am | News | Comments

Actavis plc, a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health Inc. Read more...

TOPICS:

12,000 Boxes of Pain Relief Tablets Are Being Recalled

October 22, 2014 10:20 am | News | Comments

12,000 boxes of pain relief tablets sold at are being recalled because the cartons contain a different medication that could cause allergic reactions. Read more...                 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading